CEPHAFORTE 300 ANTIBIOTIC TABLETS FOR DOGS

Negara: Australia

Bahasa: Inggris

Sumber: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Beli Sekarang

Unduh Selebaran informasi (PIL)
20-06-2017
Unduh Karakteristik produk (SPC)
20-06-2017
Unduh Lembar Data Keselamatan (SDS)
27-08-2009

Bahan aktif:

CEPHALEXIN AS CEPHALEXIN MONOHYDRATE

Tersedia dari:

JUROX PTY LIMITED

INN (Nama Internasional):

cephalexin as monohydrate(300mg/Tb)

Bentuk farmasi:

ORAL TABLET

Komposisi:

CEPHALEXIN AS CEPHALEXIN MONOHYDRATE ANTIBIOTIC Active 300.0 mg/Tb

Unit dalam paket:

10x10 Tabs; 200Tablets

Kelas:

VM - Veterinary Medicine

Kelompok Terapi:

DOG | BITCH | CASTRATE | PUPPY

Area terapi:

ANTIBIOTIC & RELATED

Indikasi Terapi:

INFECTIONS OF SOFT CUTANEOUS TISSUE | INFECTIONS OF THE DIGESTIVE TRACT | INFECTIONS OF THE RESPIRATORY TRACT | INFECTIONS OF THE URINARY TRACTS | OSTEOMYELITIS | ACUTE RESPIRATORY INFECTIONS | BRONCHISEPTICA | BRONCHITIS | ESCHERICHIA COLI | GROUP D STREPTOCOCCUS | KLEBSIELLA SPP. | PHARYNGITIS | PNEUMONIA | PROTEUS SPP. | PSEUDOMONAS AERUGINOSA | STAPHYLOCOCCUS SPP. | TONSILLITIS

Ringkasan produk:

Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: DOG: [INFECTIONS OF SOFT CUTANEOUS TISSUE, INFECTIONS OF THE DIGESTIVE TRACT, INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE URINARY TRACTS, OSTEOMYELITIS]; Poison schedule: 4; Withholding period: ; Host/pest details: DOG: [INFECTIONS OF SOFT CUTANEOUS TISSUE, INFECTIONS OF THE DIGESTIVE TRACT, INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE URINARY TRACTS, OSTEOMYELITIS]; For the treatment of infections in dogs caused by cephalexin sensitive organisms, including infections of soft cutaneous tissue, infections of the respiratory, urinary and digestive tracts, and for the prevention and treatment of osteomyelitis.Contraindicated in animals with a history of allergic reactions to cephalosporins or other penicillins. Nausea & vomiting may occasionally occur.

Status otorisasi:

Registered

Tanggal Otorisasi:

2023-07-01

Selebaran informasi

                                Cephaforte 300mg antibiotic tablets for dogs AUG09
page 1/2
(blister pack of 10 x 10 tablets)
PRIMARY CONTAINER (CARTON) MAIN PANEL
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
CEPHAFORTE 300
ANTIBIOTIC TABLETS FOR DOGS
Active Constituent:
Each tablet contains 300 mg CEPHALEXIN (as monohydrate)
FOR THE TREATMENT OF INFECTIONS IN DOGS CAUSED BY CEPHALEXIN SENSITIVE
ORGANISMS, INCLUDING INFECTIONS OF SOFT CUTANEOUS TISSUE, INFECTIONS
OF THE
RESPIRATORY, URINARY AND DIGESTIVE TRACTS, AND FOR THE PREVENTION AND
TREATMENT
OF OSTEOMYELITIS.
[100] TABLETS
[
_JUROX _
LOGO]
PRIMARY CONTAINER (CARTON) BACK PANEL
DIRECTIONS FOR USE
CONTRAINDICATION: THIS PRODUCT IS CONTRAINDICATED FOR USE IN ANIMALS
WITH A
HISTORY OF ALLERGIC REACTIONS TO CEPHALOSPORINS OR OTHER PENICILLINS.
Administer orally. Give 15mg/kg bodyweight twice per day (equivalent
to 1
Cephaforte 300 Tablet per 20kg bodyweight given night and morning). In
refractory
cases, dose may be increased to 20mg/kg twice daily (1 Cephaforte 300
Tablet per
15 kg bodyweight given night and morning).
Duration of treatment is at least 3 days, but may be extended at the
discretion of the
veterinarian.
Nausea and vomiting in dogs may occasionally occur, but these effects
are unusual
and transitory.
FIRST AID: If poisoning occurs, contact a doctor or Poisons
Information Centre.
Phone 131126.
DISPOSE of empty container by wrapping with paper and placing in
garbage.
[
_Jurox_
logo]
[Item code]
STORE below 30°C (Room Temperature)
Made in Australia by
Jurox Pty Ltd
85 Gardiner Rd
Rutherford NSW 2320
Infoline 1800 023 312
APVMA No. 60442/10x10Tab/0309
APPROVED
LABEL
Info
PEST

Verified
Cephaforte 300mg antibiotic tablets for dogs AUG09
page 2/2
(blister pack of 10 x 10 tablets)
PRIMARY CONTAINER (CARTON) SIDE PANEL 1
CEPHAFORTE 300
ANTIBIOTIC TABLETS FOR DOGS
B.
EXP.
PRIMARY CONTAINER (CARTON) SIDE PANEL 2
[BAR CODE]
PRIMARY CONTAINER (CARTON) SIDE TABS 1 AND 2
CEPHAFORTE 300
ANTIBIOTIC TABLETS FOR DOGS
BLISTER LABEL
FOR ANIMAL TREATMENT ONLY
C
                                
                                Baca dokumen lengkapnya
                                
                            

Karakteristik produk

                                CEPHAFORTE TABLETS
Page 1 of 4
ISSUED:
13 JUNE 2012
MATERIAL SAFETY DATA SHEET
SECTION 1: IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY
PRODUCT NAME:
CEPHAFORTE TABLETS
PRODUCT CODE:
503190 (300 mg tabs), 503195 (600 mg tabs)
RECOMMENDED USE:
Antibiotic tablets for dogs and cats
COMPANY IDENTIFICATION:
Jurox Pty Limited
ADDRESS:
85 Gardiner Street
Rutherford NSW 2320
Australia
CUSTOMER CENTRE:
1800 023 312
NATIONAL POISONS INFORMATION CENTRE:
131126 (Australia-wide)
EMERGENCY TELEPHONE NUMBER:
1800 023 312 (Monday – Friday, 9.00a.m. – 5.00p.m.)
SECTION 2: HAZARDS IDENTIFICATION
HAZARD CLASSIFICATIONS:
NOT CONSIDERED A HAZARDOUS SUBSTANCE ACCORDING TO THE CRITERIA OF
NOHSC
AUSTRALIA.
NOT CONSIDERED A DANGEROUS GOOD ACCORDING TO THE CRITERIA OF THE
AUSTRALIAN
DANGEROUS GOODS (ADG) CODE.
POISONS SCHEDULE:
S4
RISK PHRASES:
Cephalosporins may cause severe allergic reactions in some sensitive
individuals
Ingestion may produce health damage*
Cumulative effects may result following exposure*
(* limited evidence)
SAFETY PHRASES:
Avoid contact with skin
SECTION 3: COMPOSITION / INFORMATION ON INGREDIENTS
INGREDIENT
CAS NO.
CONTENT
Cephalexin monohydrate
23325-78-2
approx. 40%
Other ingredients determined not to be hazardous
to 100%
CEPHAFORTE TABLETS
Page 2 of 4
SECTION 4: FIRST AID MEASURES
FIRST AID MEASURES:
If swallowed do NOT induce vomiting. If vomiting occurs, lean patient
forward or place on left
side (head-down position, if possible) to maintain open airway and
prevent aspiration. Give
water to rinse mouth, then provide liquid slowly. Contact a doctor or
Poisons Information
Centre, phone 131126. If medical advice is needed, have this MSDS or
product container or
label at hand.
INHALATION:
Product may be irritating, but significant inhalation exposure is
considered to be unlikely. If
dust is inhaled, move patient to fresh air. If irritation persists,
seek medical attention.
INGESTION:
If swallowed DO NOT induce vomiting. For advice, contact a doctor or
Poisons Information
Centre, phone 131126. Seek medical ass
                                
                                Baca dokumen lengkapnya
                                
                            

Lembar Data Keselamatan

                                WWW.JUROX.COM.AU
Customer Service 1800 023 312
® Registered Trademark of Jurox Pty Ltd
TECHNICAL NOTES
ACTIVE CONSTITUENTS
Cephalexin 300 mg/tablet, 600 mg/tablet.
ACTIONS
Cephalexin is a broad spectrum cephalosporin antibiotic which is
chemically related to penicillin. Based on its broad spectrum of
activity, cephalexin makes an ideal choice for trauma cases where
diffusion into bone and joints may be important. It provides a good
treatment and prevention for osteomyelitis and supports the needs of
surgical prophylaxis. In cases of persistent infection (pyodermas
and abscesses) cephalexin is ideal for long-term therapy.
MICROBIOLOGY: As cephalexin is resistant to the action of
β-lactamases, Cephaforte is active against strains of _Staphylococcus
aureus_
that are insensitive to penicillin (or related antibiotics such as
ampicillin or amoxycillin). Cephalexin has bactericidal activity
against
a wide range of Gram-positive and Gram-negative bacteria, including
_Staphylococcus_ spp., _Streptococcus_ spp., _Corynebacterium_ spp.,
_Pasteurella multocida, Escherichia coli,_ _Proteus_ spp.,
_Micrococcus _spp. and _Moraxella_ spp., causing death of bacterial
cells through a
diversity of biological and biochemical effects on the cell wall.
PHARMACOKINETICS: Cephalexin is acid stable and active when
administered orally. Cephalexin has an excellent absorption profile,
with distribution through most body fluids and tissues including
kidneys, lungs, joints, bone, soft tissues and biliary tract.
Cephalexin is
excreted unmetabolised in the urine, and so provides high and
sustained antibiotic levels in cases of urinary tract infections
(UTIs), and
such levels are minimally affected by the usual variations in urinary
pH associated with UTIs. Removal of the active agent is primarily
through glomerular filtration through the kidneys as well as some
tubular secretion. The elimination half-life of cephalexin is about
one to two hours in dogs and cats.
INDICATIONS
Treatment of infections in dogs and cats caused by
cephalexin-sensiti
                                
                                Baca dokumen lengkapnya